Works by Lee, Jae‐Lyun

Results: 118

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.

Published in:

2020

By:

Park, Ji Hyun;
Lee, Ji Sung;
Koo, HaYeong;
Kim, Jeong Eun;
Ahn, Jin-Hee;
Ryu, Min-Hee;
Park, Sook-ryun;
Yoon, Shin-kyo;
Lee, Jae Cheol;
Hong, Yong-Sang;
Kim, Sun Young;
Kim, Kyo-Pyo;
Yoo, Chang-Hoon;
Hong, Jung Yong;
Lee, Jae Lyun;
Jung, Kyung Hae;
Rhyoo, Baek-Yeol;
Kim, Tae Won

Publication type:

journal article

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.

Published in:

BMC Medical Genomics, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s12920-018-0406-2

By:

Ansari, Adnan Ahmad;
Park, Inkeun;
Kim, Inki;
Park, Sojung;
Ahn, Sung-Min;
Lee, Jae-lyun

Publication type:

Article

Analysis of Anti-Angiogenesis-Related Adverse Events Associated with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors (VEGFR-TKIs) in Patients with Metastatic Renal Cell Carcinoma.

Published in:

Targeted Oncology, 2023, v. 18, n. 2, p. 247, doi. 10.1007/s11523-023-00951-z

By:

Lee, Nuri;
Lee, Jae Lyun;
Lee, Ju-Yeun

Publication type:

Article

Timing of antibiotic administration and outcomes in patients with chemotherapy-induced febrile neutropenia.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 221, doi. 10.1002/hon.2045

By:

Ahn, Shin;
Lee, Yoon‐Seon;
Lim, Kyung Soo;
Lee, Jae‐Lyun

Publication type:

Article

Emergency department cancer unit and management of oncologic emergencies: experience in Asan Medical Center.

Published in:

Supportive Care in Cancer, 2012, v. 20, n. 9, p. 2205, doi. 10.1007/s00520-012-1478-8

By:

Ahn, Shin;
Lee, Yoon-Seon;
Lim, Kyung;
Lee, Jae-Lyun

Publication type:

Article

Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine–cisplatin and high dose-intensity MVAC.

Published in:

Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 11, p. 3421, doi. 10.1007/s00432-021-03582-x

By:

Lee, Yongjune;
Kim, Young Seok;
Hong, Bumsik;
Cho, Yong Mee;
Lee, Jae-Lyun

Publication type:

Article

Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 11, p. 2331, doi. 10.1007/s00432-016-2217-1

By:

You, Dalsan;
Lee, Chunwoo;
Jeong, In;
Song, Cheryn;
Lee, Jae-Lyun;
Hong, Bumsik;
Hong, Jun;
Ahn, Hanjong;
Kim, Choung-Soo

Publication type:

Article

The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy.

Published in:

Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 10, p. 1751, doi. 10.1007/s00432-014-1703-6

By:

Kwon, Taekmin;
Lee, Jae-Lyun;
Kim, Jeong;
You, Dalsan;
Jeong, In;
Song, Cheryn;
Ahn, Hanjong;
Kim, Choung-Soo;
Hong, Jun

Publication type:

Article

Active surveillance for metastatic or recurrent renal cell carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 8, p. 1421, doi. 10.1007/s00432-014-1680-9

By:

Park, Inkeun;
Lee, Jae-Lyun;
Ahn, Jin-Hee;
Lee, Dae-Ho;
Lee, Kyoo-Hyung;
Jeong, In;
Song, Cheryn;
Hong, Bumsik;
Hong, Jun;
Ahn, Hanjong

Publication type:

Article

Erratum to: Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component.

Published in:

2013

By:

Park, Inkeun;
Cho, Yong;
Lee, Jae-Lyun;
Ahn, Jin-Hee;
Lee, Dae-Ho;
Song, Cheryn;
Hong, Jun-Hyuk;
Kim, Choung-Soo;
Ahn, Hanjong

Publication type:

Correction Notice

Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component.

Published in:

Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 817, doi. 10.1007/s00432-013-1386-4

By:

Park, Inkeun;
Cho, Yong;
Lee, Jae-Lyun;
Ahn, Jin-Hee;
Lee, Dae-Ho;
Song, Cheryn;
Hong, Jun-Hyuk;
Kim, Choung-Soo;
Ahn, Hanjong

Publication type:

Article

Efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma and poor risk features.

Published in:

Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 4, p. 687, doi. 10.1007/s00432-012-1148-8

By:

Lee, Jae-Lyun;
Park, Inkeun;
Park, Kwonoh;
Park, Seongjoon;
Ahn, Yongcheol;
Ahn, Jin-Hee;
Kim, Tae-Won;
Ahn, Shin;
Song, Cheryn;
Hong, Jun;
Kim, Choung-Soo;
Ahn, Hanjong

Publication type:

Article

Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.

Published in:

Gastric Cancer, 2015, v. 18, n. 2, p. 346, doi. 10.1007/s10120-014-0385-8

By:

Koo, Dong;
Ryu, Min-Hee;
Ryoo, Baek-Yeol;
Seo, Jinjoo;
Lee, Mi-Yeon;
Chang, Heung-Moon;
Lee, Jae-Lyun;
Lee, Sung-Sook;
Kim, Tae;
Kang, Yoon-Koo

Publication type:

Article

Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.

Published in:

Gastric Cancer, 2012, v. 15, n. 3, p. 305, doi. 10.1007/s10120-011-0117-2

By:

Koo, Dong Hoe;
Ryu, Min-Hee;
Ryoo, Baek-Yeol;
Lee, Sung-Sook;
Moon, Jung-Hwa;
Chang, Heung-Moon;
Lee, Jae-Lyun;
Kim, Tae Won;
Kang, Yoon-Koo

Publication type:

Article

Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y

By:

van der Heijden, Michiel S.;
Powles, Thomas;
Petrylak, Daniel;
de Wit, Ronald;
Necchi, Andrea;
Sternberg, Cora N.;
Matsubara, Nobuaki;
Nishiyama, Hiroyuki;
Castellano, Daniel;
Hussain, Syed A.;
Bamias, Aristotelis;
Gakis, Georgios;
Lee, Jae-Lyun;
Tagawa, Scott T.;
Vaishampayan, Ulka;
Aragon-Ching, Jeanny B.;
Eigl, Bernie J.;
Hozak, Rebecca R.;
Rasmussen, Erik R.;
Xia, Meng Summer

Publication type:

Article

Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma.

Published in:

Acta Oncologica, 2012, v. 51, n. 7, p. 860, doi. 10.3109/0284186X.2012.682628

By:

Kang, Myoung Joo;
Lee, Jae-Lyun;
Kim, Tae Won;
Lee, Sung Sook;
Ahn, Shin;
Park, Do Hyun;
Lee, Sang Soo;
Seo, Dong Wan;
Lee, Sung Koo;
Kim, Myung-Hwan

Publication type:

Article

Efficacy of Neoadjuvant Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma.

Published in:

Acta Oncologica, 2003, v. 42, n. 3, p. 207, doi. 10.1080/02841860310010736

By:

Lee, Jae-lyun;
Kim, Sung-bae;
Jung, Hwoon-yong;
Park, Seung-il;
Kim, Dong-kwan;
Kim, Jong-hoon;
Song, Ho-young;
Kim, Woo-kun;
Lee, Jung-shin;
Min, Young-il

Publication type:

Article

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial.

Published in:

2018

By:

Yeon Joo Kim;
Hanjong Ahn;
Choung-Soo Kim;
Jae-Lyun Lee;
Young Seok Kim;
Kim, Yeon Joo;
Ahn, Hanjong;
Kim, Choung-Soo;
Lee, Jae-Lyun;
Kim, Young Seok

Publication type:

journal article

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Published in:

2016

By:

Kaymakcalan, Marina D.;
Xie, Wanling;
Albiges, Laurence;
North, Scott A.;
Kollmannsberger, Christian K.;
Smoragiewicz, Martin;
Kroeger, Nils;
Wells, J. Connor;
Rha, Sun‐Young;
Lee, Jae Lyun;
McKay, Rana R.;
Fay, André P.;
De Velasco, Guillermo;
Heng, Daniel Y. C.;
Choueiri, Toni K.

Publication type:

journal article

A Phase I Study of UGT1A1 28/6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI.

Published in:

Oncology, 2015, v. 88, n. 3, p. 164, doi. 10.1159/000368674

By:

Kim, Kyu-Pyo;
Hong, Yong Sang;
Lee, Jae-Lyun;
Bae, Kyun Seop;
Kim, Ho-Sook;
Shin, Jae-Gook;
Lee, Jung Shin;
Kim, Tae Won

Publication type:

Article

TFAP2E Methylation Status and Prognosis of Patients with Radically Resected Colorectal Cancer.

Published in:

Oncology, 2015, v. 88, n. 2, p. 122, doi. 10.1159/000362820

By:

Park, Seong Joon;
Kim, Seung-mi;
Hong, Yong Sang;
Lee, Jae-Lyun;
Kim, Jeong-Eun;
Kim, Kyu-pyo;
Hong, Seung-Mo;
Jin, Dong-Hoon;
Kim, Chan Wook;
Yoon, Yong Sik;
Park, In Ja;
Lim, Seok-Byung;
Yu, Chang Sik;
Kim, Jin Cheon;
Kim, Tae Won

Publication type:

Article

A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical Activity.

Published in:

Oncology, 2012, v. 82, n. 5, p. 290, doi. 10.1159/000337989

By:

Choi, Yoon Hee;
Kim, Tae Won;
Kim, Kyu-Pyo;
Lee, Sung Sook;
Hong, Yong Sang;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung Moon;
Ryoo, Baek-Yeol;
Kim, Ho-Sook;
Shin, Jae-Gook;
Kang, Yoon-Koo

Publication type:

Article

Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer.

Published in:

Oncology, 2012, v. 82, n. 2, p. 83, doi. 10.1159/000335959

By:

Park, Seong Joon;
Hong, Yong Sang;
Lee, Jae-Lyun;
Ryu, Min-Hee;
Chang, Heung Moon;
Kim, Kyu-pyo;
Ahn, Yong Chel;
Na, Young-Soon;
Jin, Dong-Hoon;
Yu, Chang Sik;
Kim, Jin Cheon;
Kang, Yoon-Koo;
Kim, Tae Won

Publication type:

Article

Adjuvant Chemotherapy for Small Bowel Adenocarcinoma after Curative Surgery.

Published in:

Oncology, 2011, v. 80, n. 3/4, p. 208, doi. 10.1159/000328506

By:

Koo, Dong Hoe;
Yun, Sung-Cheol;
Hong, Yong Sang;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung-Moon;
Kang, Yoon-Koo;
Kim, Song-Cheol;
Han, Duck-Jong;
Lee, Young-Joo;
Kim, Tae Won

Publication type:

Article

PDGFRα Gene Mutation and Protein Expression in Gastrointestinal Stromal Tumors.

Published in:

Oncology, 2008, v. 74, n. 1/2, p. 88, doi. 10.1159/000139136

By:

Chang, Heung Moon;
Ryu, Min-Hee;
Lee, Hyoungnam;
Jang, Se Jin;
Lee, Jae-Lyun;
Kim, Tae Won;
Yook, Jeong Hwan;
Oh, Sung Tae;
Kim, Byung Sik;
Lee, Jung Shin;
Kang, Yoon-Koo

Publication type:

Article

Improving the Quality of Cancer Pain Management in an Academic Medical Center Emergency Department.

Published in:

Clinical Journal of Oncology Nursing, 2014, v. 18, n. 6, p. 626, doi. 10.1188/14.CJON.626-629

By:

Won, Young Hwa;
Choi, Yun Jung;
Ahn, Shin;
Lee, Jae-Lyun;
Park, Jeong Yun;
Kim, Sulhwa;
Kim, Tae Won;
Kim, Yeon Hee

Publication type:

Article

Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration.

Published in:

BJU International, 2021, v. 128, n. 5, p. 607, doi. 10.1111/bju.15434

By:

Ravi, Praful;
Pond, Gregory R.;
Diamantopoulos, Leonidas N.;
Su, Christopher;
Alva, Ajjai;
Jain, Rohit K.;
Skelton, William P.;
Gupta, Sumati;
Tward, Jonathan D.;
Olson, Kathleen M.;
Singh, Parminder;
Grunewald, Camilla M.;
Niegisch, Guenter;
Lee, Jae‐Lyun;
Gallina, Andrea;
Bandini, Marco;
Necchi, Andrea;
Mossanen, Matthew;
McGregor, Bradley A.;
Curran, Catherine

Publication type:

Article

Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y

By:

van der Heijden, Michiel S.;
Powles, Thomas;
Petrylak, Daniel;
de Wit, Ronald;
Necchi, Andrea;
Sternberg, Cora N.;
Matsubara, Nobuaki;
Nishiyama, Hiroyuki;
Castellano, Daniel;
Hussain, Syed A.;
Bamias, Aristotelis;
Gakis, Georgios;
Lee, Jae-Lyun;
Tagawa, Scott T.;
Vaishampayan, Ulka;
Aragon-Ching, Jeanny B.;
Eigl, Bernie J.;
Hozak, Rebecca R.;
Rasmussen, Erik R.;
Xia, Meng Summer

Publication type:

Article

Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures.

Published in:

2019

By:

Park, Inkeun;
Shim, Young Sup;
Go, Heounjeong;
Hong, Bum Sik;
Lee, Jae Lyun

Publication type:

journal article

A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma.

Published in:

2016

By:

Moon Jin Kim;
Se Hoon Park;
Jae-Lyun Lee;
Se-Hoon Lee;
Su Jin Lee;
Ho Yeong Lim;
Kim, Moon Jin;
Park, Se Hoon;
Lee, Jae-Lyun;
Lee, Se-Hoon;
Lee, Su Jin;
Lim, Ho Yeong

Publication type:

journal article

Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRAS.

Published in:

Cancer Science, 2013, v. 104, n. 4, p. 473, doi. 10.1111/cas.12098

By:

Hong, Yong Sang;
Kim, Hwa Jung;
Park, Seong Joon;
Kim, Kyu‐Pyo;
Lee, Jae‐Lyun;
Park, Jin Hong;
Kim, Jong Hoon;
Lim, Seok‐Byung;
Yu, Chang Sik;
Kim, Jin Cheon;
Baek, Ji Yeon;
Kim, Sun Young;
Kim, Tae Won

Publication type:

Article

Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer.

Published in:

Cancer Science, 2013, v. 104, n. 1, p. 111, doi. 10.1111/cas.12041

By:

Lee, Eun Mi;
Hong, Yong Sang;
Kim, Kyu‐pyo;
Lee, Jae‐Lyun;
Kim, Sun Young;
Park, Young Suk;
Choi, Doo Ho;
Kim, Jong Hoon;
Lim, Seok‐Byung;
Yu, Chang Sik;
Kim, Jin Cheon;
Lee, Ju Hee;
Kim, Ah Young;
Kim, Tae Won

Publication type:

Article

Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer.

Published in:

Cancer Science, 2011, v. 102, n. 9, p. 1706, doi. 10.1111/j.1349-7006.2011.02009.x

By:

Kim, Jeong Eun;
Hong, Yong Sang;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung Moon;
Lim, Seok-Byung;
Kim, Jong Hoon;
Jang, Se-Jin;
Kim, Mi-Jung;
Yu, Chang Sik;
Kang, Yoon-Koo;
Kim, Jin Cheon;
Kim, Tae Won

Publication type:

Article

Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma.

Published in:

World Journal of Urology, 2015, v. 33, n. 1, p. 111, doi. 10.1007/s00345-014-1295-4

By:

You, Dalsan;
Song, Sang;
Cho, Yong;
Lee, Jae-Lyun;
Jeong, In;
Song, Cheryn;
Hong, Jun;
Kim, Choung-Soo;
Ahn, Hanjong

Publication type:

Article

Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.

Published in:

Pathology & Oncology Research, 2019, v. 25, n. 1, p. 51, doi. 10.1007/s12253-017-0323-2

By:

Go, Heounjeong;
Kang, Mun Jung;
Kim, Pil-Jong;
Lee, Jae-Lyun;
Park, Ji Y.;
Park, Ja-Min;
Ro, Jae Y.;
Cho, Yong Mee

Publication type:

Article

Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.

Published in:

2017

By:

Lee, Ji;
Song, Cheryn;
Hong, Bum;
Hong, Jun;
Ahn, Hanjong;
Lee, Jae;
Lee, Ji Young;
Hong, Bum Sik;
Hong, Jun Hyuk;
Lee, Jae Lyun

Publication type:

journal article

Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.

Published in:

2016

By:

Kim, Jwa;
Park, Inkeun;
Lee, Jae;
Kim, Jwa Hoon;
Lee, Jae Lyun

Publication type:

journal article

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma.

Published in:

2016

By:

Koo, Dong-Hoe;
Park, Inkeun;
Ahn, Jin-Hee;
Lee, Dae-Ho;
You, Dalsan;
Jeong, In-Gab;
Song, Cheryn;
Hong, Bumsik;
Hong, Jun;
Ahn, Hanjong;
Lee, Jae-Lyun;
Hong, Jun Hyuk

Publication type:

journal article

Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1025, doi. 10.1007/s00280-015-2725-8

By:

Park, Inkeun;
Lee, Jae-Lyun;
Ahn, Jin-Hee;
Lee, Dae-Ho;
Lee, Kyoo-Hyung;
You, Dalsan;
Jeong, In;
Song, Cheryn;
Hong, Bumsik;
Hong, Jun;
Ahn, Hanjong

Publication type:

Article

Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 2, p. 247, doi. 10.1007/s00280-014-2640-4

By:

Park, Ji;
Lee, Jae-Lyun

Publication type:

Article

Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 5, p. 1005, doi. 10.1007/s00280-014-2579-5

By:

Lee, Jae-Lyun;
Park, Se;
Koh, Su-Jin;
Lee, Se;
Kim, Yu;
Choi, Yoon;
Lee, Jihye;
Lim, Ho

Publication type:

Article

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)

Published in:

2014

By:

Kang, Yoon-Koo;
Yook, Jeong Hwan;
Chang, Heung-Moon;
Ryu, Min-Hee;
Yoo, Changhoon;
Zang, Dae Young;
Lee, Jae-Lyun;
Kim, Tae Won;
Yang, Dae Hyun;
Jang, Se Jin;
Park, Young Soo;
Lee, Young Jack;
Jung, Hwoon-Yong;
Kim, Jin-Ho;
Kim, Byung Sik

Publication type:

Journal Article

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 139, doi. 10.1007/s00280-013-2332-5

By:

Kang, Yoon-Koo;
Yook, Jeong;
Chang, Heung-Moon;
Ryu, Min-Hee;
Yoo, Changhoon;
Zang, Dae;
Lee, Jae-Lyun;
Kim, Tae;
Yang, Dae;
Jang, Se;
Park, Young;
Lee, Young;
Jung, Hwoon-Yong;
Kim, Jin-Ho;
Kim, Byung

Publication type:

Article

Erratum to: Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.

Published in:

2013

By:

Kang, Yoon-Koo;
Kang, Byung;
Im, Seock-Ah;
Lee, Jae-Lyun;
Park, Sook;
Kang, Won;
Chang, Heung;
Kim, Tae;
Oh, Do-Youn;
Jung, Kyung;
Ryu, Min-Hee

Publication type:

Correction Notice

Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 43, doi. 10.1007/s00280-012-1970-3

By:

Kang, Yoon-Koo;
Kang, Byung;
Im, Seock-Ah;
Lee, Jae-Lyun;
Park, Sook;
Kang, Won;
Chang, Heung;
Kim, Tae;
Oh, Do-Youn;
Jung, Kyung;
Ryu, Min-Hee

Publication type:

Article

A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 905, doi. 10.1007/s00280-011-1562-7

By:

Choi, Yoon;
Kim, Tae;
Lee, Sung;
Hong, Yong;
Ryu, Min-Hee;
Lee, Jae-Lyun;
Chang, Heung;
Kang, Yoon-Koo

Publication type:

Article

A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 4, p. 913, doi. 10.1007/s00280-011-1561-8

By:

Koo, Dong;
Ryoo, Baek-Yeol;
Kim, Hwa;
Ryu, Min-Hee;
Lee, Sung-Sook;
Moon, Jung-Hwa;
Chang, Heung-Moon;
Lee, Jae-Lyun;
Kim, Tae;
Kang, Yoon-Koo

Publication type:

Article

Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 2, p. 285, doi. 10.1007/s00280-010-1479-6

By:

Kim, Kyu-pyo;
Ryu, Min-Hee;
Yoo, Changhoon;
Ryoo, Baek-Yeol;
Choi, Dae;
Chang, Heung;
Lee, Jae-Lyun;
Beck, Mo;
Kim, Tae;
Kang, Yoon-Koo

Publication type:

Article

A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 631, doi. 10.1007/s00280-007-0516-6

By:

Lee, Jae-Lyun;
Ryu, Min-Hee;
Chang, Heung;
Kim, Tae-Won;
Yook, Jeong;
Oh, Sung;
Kim, Byung;
Kim, Minsun;
Chun, Young;
Lee, Jung;
Kang, Yoon-Koo

Publication type:

Article

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 623, doi. 10.1007/s00280-007-0515-7

By:

Park, Yeon;
Lee, Jae-Lyun;
Ryoo, Baek-Yeol;
Ryu, Min-Hee;
Yang, Sung;
Kim, Bong;
Shin, Dong;
Chang, Heung;
Kim, Tae;
Yuh, Young;
Kang, Yoon-Koo

Publication type:

Article